Axsome Therapeutics (AXSM) PT Raised to $255 at TD Cowen
TD Cowen analyst Joseph Thome raised the price target on Axsome Therapeutics (NASDAQ: AXSM) to $255.00 (from $215.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)